Rapid diagnostic test evaluation in the Democratic Republic of the Congo, part of the BRIDGE Dx Access initiative (provisional wording)
- Funded by Foreign, Commonwealth & Development Office (FCDO)
- Total publications:0 publications
Grant search
Key facts
Disease
EbolaStart & end year
2026Known Financial Commitments (USD)
$1,691,046Funder
Foreign, Commonwealth & Development Office (FCDO)Research Location
Congo (DRC)Lead Research Institution
PATHResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
DiagnosticsSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable
Abstract
FCDO grant to PATH for a diagnostics validation initiative with WHO and other partners, focused on evaluating rapid diagnostic tests in the Democratic Republic of the Congo during the 2026 Bundibugyo virus disease outbreak.